DGX · News · 20260805N

Market Demand Trends

QUEST DIAGNOSTICS INC · 2026-08-05 · Importance 67 · Surprise 76

Quest Diagnostics reported accelerated testing demand across various channels, with volume growth contributing to its improved outlook. The company raised its 2026 revenue and adjusted earnings outlook in connection with the stronger demand. Reporting noted that lower-margin partnerships and higher operational spending could affect the profitability of this growth.

Key facts

• Arrowstreet Capital Limited Partnership initiated a new position in Quest Diagnostics by acquiring 11,468 shares valued at approximately $2.25 million source
• Institutional investors now own 88.06% of Quest Diagnostics source
• The consensus rating for DGX remains a "Hold" with an average target price of $235.31 source